Repository logo
 
Publication

Self‐assembly of cholesterol‐Doxorubicin and TPGS into Prodrug‐based nanoparticles with enhanced cellular uptake and Lysosome‐dependent pathway in breast cancer cells

dc.contributor.authorOlim, Filipe
dc.contributor.authorNeves, Ana Rute
dc.contributor.authorVieira, Mariana
dc.contributor.authorTomás, Helena
dc.contributor.authorSheng, Ruilong
dc.date.accessioned2021-11-16T15:05:33Z
dc.date.available2021-11-16T15:05:33Z
dc.date.issued2021
dc.description.abstractDeveloping new easy-to-prepare functional drug delivery nanosystems with good storage stability, low hemotoxicity, as well as controllable drug delivery property, has attracted great attention in recent years. In this work, a cholesterol-based prodrug nanodelivery system is prepared by self-assembly of cholesterol-doxorubicin prodrug conjugates (Chol-Dox) and tocopherol polyethylene glycol succinate (TPGS) using thin-film hydration method. The Chol-Dox/TPGS assemblies (molar ratio 2:1, 1:1, and 1:2) are able to form nanoparticles with average hydrodynamic diameter of ≈140–214 nm, surface zeta potentials of ≈−24.2–−0.3 mV, and remarkable solution stability in 0.1 m PBS, 16 days). The Chol-Dox/TPGS assemblies show low hemotoxicity and different cytotoxicity profiles in breast cancer cells (MCF-7 and MDA-MB-231), which are largely dependent on the molar ratio of Chol-Dox and TPGS. The Chol-Dox/TPGS assemblies tend to enter into MCF-7 and MDA-MB-231 cells through non-Clathrin-mediated multiple endocytosis and lysosome-dependent uptake pathways, moreover, these nanoassemblies demonstrate lysosome-dependent intracellular localization, which is different from that of free DOX (nuclear localization). The results demonstrate that the Chol-Dox/TPGS assemblies are promising cholesterol-based prodrug nanomaterials for breast cancer chemotherapy. Practical Applications: This work demonstrates a lipid prodrug-based nanotherapeutic system. Herein the Chol-Dox/TPGS nanoassemblies could serve as promising and controllable cholesterol-based prodrug nanomaterials/nano-formulations for potential breast cancer chemotherapy.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationOlim, F., Neves, A. R., Vieira, M., Tomás, H., & Sheng, R. (2021). Self‐assembly of cholesterol‐Doxorubicin and TPGS into Prodrug‐based nanoparticles with enhanced cellular uptake and Lysosome‐dependent pathway in breast cancer cells. European Journal of Lipid Science and Technology, 123(5), 2000337. https://doi.org/10.1002/ejlt.202000337pt_PT
dc.identifier.doi10.1002/ejlt.202000337pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.13/3822
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherWileypt_PT
dc.relationMadeira Chemistry Research Centre
dc.relationMadeira Chemistry Research Centre
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectSelf-assembly of cholesterol-doxorubicinpt_PT
dc.subjectProdrug-based nanoparticlespt_PT
dc.subjectEnhanced cellular uptakept_PT
dc.subjectLysosome-dependentpt_PT
dc.subjectBreast cancer cellspt_PT
dc.subjectCholesterol-doxorubicinpt_PT
dc.subject.pt_PT
dc.subjectFaculdade de Ciências Exatas e da Engenhariapt_PT
dc.subjectCentro de Química da Madeira
dc.titleSelf‐assembly of cholesterol‐Doxorubicin and TPGS into Prodrug‐based nanoparticles with enhanced cellular uptake and Lysosome‐dependent pathway in breast cancer cellspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleMadeira Chemistry Research Centre
oaire.awardTitleMadeira Chemistry Research Centre
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00674%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00674%2F2020/PT
oaire.citation.issue5pt_PT
oaire.citation.startPage2000337pt_PT
oaire.citation.titleEuropean Journal of Lipid Science and Technologypt_PT
oaire.citation.volume123pt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
person.familyNameOlim
person.familyNameNeves
person.familyNameCatanho da Silva Vieira
person.familyNameTomás
person.familyNameSheng
person.givenNameFilipe
person.givenNameAna Rute
person.givenNameMariana
person.givenNameHelena
person.givenNameRuilong
person.identifier556975
person.identifierhttps://scholar.google.ca/citations?user=YCheaFsAAAAJ&hl=en
person.identifier.ciencia-id911A-2894-E357
person.identifier.ciencia-idA51A-E760-E8B8
person.identifier.ciencia-idA915-E451-9EE1
person.identifier.ciencia-id4D14-D31E-A8BE
person.identifier.ciencia-idC019-C809-403B
person.identifier.orcid0000-0001-8878-2067
person.identifier.orcid0000-0003-4262-5837
person.identifier.orcid0000-0001-5928-4237
person.identifier.orcid0000-0002-7856-2041
person.identifier.orcid0000-0002-3303-3832
person.identifier.ridO-6395-2018
person.identifier.ridH-3743-2013
person.identifier.ridE-5991-2010
person.identifier.scopus-author-id56731303900
person.identifier.scopus-author-id6508104177
person.identifier.scopus-author-id7005472737
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication7b5e3c58-8660-433f-913b-a6586d86d6b3
relation.isAuthorOfPublication095a50e4-1c1f-4589-ad19-f2564ec76a13
relation.isAuthorOfPublicationa98e3568-7a2a-4b9e-b13b-b570bf64d472
relation.isAuthorOfPublication3a747114-6ab9-454b-985b-00cbf792e273
relation.isAuthorOfPublication447440d5-343e-4804-a4fb-98584bb0749c
relation.isAuthorOfPublication.latestForDiscoverya98e3568-7a2a-4b9e-b13b-b570bf64d472
relation.isProjectOfPublicatione30e13d9-be9a-4f34-91ea-a1682abce74e
relation.isProjectOfPublicatione64ad36a-83b5-467c-bbb3-449ffc0662f2
relation.isProjectOfPublication.latestForDiscoverye64ad36a-83b5-467c-bbb3-449ffc0662f2

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Self‐Assembly of Cholesterol‐Doxorubicin and TPGS into Prodrug‐Based Nanoparticles with Enhanced Cellular Uptake and Lysosome‐Dependent Pathway in Breast Cancer Cells.pdf
Size:
1.75 MB
Format:
Adobe Portable Document Format